Hong Kong/China M&A/Events

Hong Kong/China M&A/Events

Henlius (2696 HK): Circ Out. 22nd Jan H-Class Meeting

Quiddity Research's avatar
Quiddity Research
Dec 23, 2024
∙ Paid
Share
  • After Shanghai Henlius Biotech (2696 HK) secured NDRC approval on the 22nd Nov; fulfilled pre-cons on the 16th December, the Circular was dispatched last night, the 22nd December.

  • The EGM/H-share class meeting will take place on the 22nd January, one day past my estimate. Settlement should be on ore around the 18th Feb, a week beyond my estimate.

  • Trading at a gross/annualised spread off 2.9%/20.3%. Still attractive here.

Keep reading with a 7-day free trial

Subscribe to Hong Kong/China M&A/Events to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Quiddity Investment Advisors
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture